Effect of capsaicin on breast cancer resistance protein (BCRP/Abcg2) and pharmacokinetics of probe substrates in rats

References

• Chanda S, Bashir M, Babbar S, Koganti A, Bley K. 2008. In vitro hepatic and skin metabolism of capsaicin. Drug Metab Dispos. 36(4):670–675.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhai X, Zhu C, Lu Y. 2015. Effects of capsaicin on pharmacokinetics of pitavastatin in rats. Xenobiotica. 45(2):171–176.
   PubMed Web of Science ®Google Scholar
• Chen XW, Serag ES, Sneed KB, Zhou SF. 2011. Herbal bioactivation, molecular targets and the toxicity relevance. Chem Biol Interact. 192(3):161–176.
   PubMed Web of Science ®Google Scholar
• Choi J, Fenando A. 2021. Sulfasalazine. Treasure Island (FL): StatPearls Publishing. [accessed 2021 Jun 29]. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=32491741&query_hl=ur1.
   Google Scholar
• Doyle L, Ross DD. 2003. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 22(47):7340–7358.
   PubMed Web of Science ®Google Scholar
• Dufour R, Daumar P, Mounetou E, Aubel C, Kwiatkowski F, Abrial C, Vatoux C, Penault-Llorca F, Bamdad M. 2015. BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib. Sci Rep. 5:12670.
   PubMed Web of Science ®Google Scholar
• Endres CJ, Hsiao P, Chung FS, Unadkat JD. 2006. The role of transporters in drug interactions. Eur J Pharm Sci. 27(5):501–517.
   PubMed Web of Science ®Google Scholar
• FDA: Drug Development and Drug Interactions | Table of Substrates, Inhibitors and Inducers. 2020. United States: Food & Drug Administration. [accessed 2020 Oct 3]. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm#table5-1.
   Google Scholar
• Govindarajan VS, Sathyanarayana MN. 1991. Capsicum-production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism; structure, pungency, pain, and desensitization sequences. Crit Rev Food Sci Nutr. 29(6):435–474.
   PubMed Web of Science ®Google Scholar
• Jelicic ML, Brusac E, Kurajica S, Cvetnic M, Amidzic KD, Nigovic B, Mornar A. 2021. Drug-drug compatibility evaluation of sulfasalazine and folic acid for fixed-dose combination development using various analytical tools. Pharmaceutics. 13(3):400.
   PubMed Web of Science ®Google Scholar
• Julius D, Basbaum AI. 2001. Molecular mechanisms of nociception. Nature. 413(6852):203–210.
   PubMed Web of Science ®Google Scholar
• Kawada T, Suzuki T, Takahashi M, Iwai K. 1984. Gastrointestinal absorption and metabolism of capsaicin and dihydrocapsaicin in rats. Toxicol Appl Pharmacol. 72(3):449–456.
   PubMed Web of Science ®Google Scholar
• Korel F, Bagdatlioglu N, Balaban MO, Hişil Y. 2002. Ground red peppers: capsaicinoids content, Scoville scores, and discrimination by an electronic nose. J Agric Food Chem. 50(11):3257–3261.
   PubMed Web of Science ®Google Scholar
• Kurita S, Kitagawa E, Kim CH, Momose Y, Iwahashi H. 2002. Studies on the antimicrobial mechanisms of capsaicin using yeast DNA microarray. Biosci Biotechnol Biochem. 66(3):532–536.
   PubMed Web of Science ®Google Scholar
• Lecerf-Schmidt F, Peres B, Valdameri G, Gauthier C, Winter E, Payen L, Di Pietro A, Boumendjel A. 2013. ABCG2: recent discovery of potent and highly selective inhibitors. Future Med Chem. 5(9):1037–1045.
   PubMed Web of Science ®Google Scholar
• Mao Q, Conseil G, Gupta A, Cole SP, Unadkat JD. 2004. Functional expression of the human breast cancer resistance protein in Pichia pastoris. Biochem Biophys Res Commun. 320(3):730–737.
   PubMed Web of Science ®Google Scholar
• Mao Q, Unadkat JD. 2015. Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport – an update. Aaps J. 17(1):65–82.
   PubMed Web of Science ®Google Scholar
• Mark H, Peter CAK. 2008. Capsaicin: a review of its pharmacology and clinical applications. Curr Anaesth Crit Care. 19(5–6):338–343.
   Google Scholar
• Meghvansi MK, Siddiqui S, Khan MH, Gupta VK, Vairale MG, Gogoi HK, Singh L. 2010. Naga chilli: a potential source of capsaicinoids with broad-spectrum ethnopharmacological applications. J Ethnopharmacol. 132(1):1–14.
   PubMed Web of Science ®Google Scholar
• Monsereenusorn Y, Kongsamut S, Pezalla PD. 1982. Capsaicin-a literature survey. Crit Rev Toxicol. 10(4):321–339.
   PubMed Web of Science ®Google Scholar
• Nascimento PL, Nascimento TC, Ramos NS, Silva GR, Gomes JE, Falcao RE, Moreira KA, Porto AL, Silva TM. 2014. Quantification, antioxidant and antimicrobial activity of phenolics isolated from different extracts of Capsicum frutescens (Pimenta Malagueta). Molecules. 19(4):5434–5447.
   PubMed Web of Science ®Google Scholar
• Natarajan K, Xie Y, Baer MR, Ross DD. 2012. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol. 83(8):1084–1103.
   PubMed Web of Science ®Google Scholar
• Noguchi K, Katayama K, Sugimoto Y. 2014. Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics. Pharmgenomics Pers Med. 7:53–64.
   PubMedGoogle Scholar
• O'Neill J, Brock C, Olesen AE, Andresen T, Nilsson M, Dickenson AH. 2012. Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev. 64(4):939–971.
   PubMed Web of Science ®Google Scholar
• Pawłowska M, Augustin E. 2011. Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro. Postepy Hig Med Dosw (Online). 65:367–376.
   PubMedGoogle Scholar
• Qadir M, O'Loughlin KL, Fricke SM, Williamson NA, Greco WR, Minderman H, Baer MR. 2005. Cyclosporin A is a broad-spectrum multidrug resistance modulator. Clin Cancer Res. 11(6):2320–2326.
   PubMed Web of Science ®Google Scholar
• Rains CP, Noble S, Faulds D. 1995. Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis. Drugs. 50(1):137–156.
   PubMed Web of Science ®Google Scholar
• Shiobara T, Usui T, Han J, Isoda H, Nagumo Y. 2013. The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin. PLoS One. 8(11):e79954.
   PubMed Web of Science ®Google Scholar
• Stacy AE, Jansson PJ, Richardson DR. 2013. Molecular pharmacology of ABCG2 and its role in chemoresistance. Mol Pharmacol. 84(5):655–669.
   PubMed Web of Science ®Google Scholar
• Tsukura Y, Mori M, Hirotani Y, Ikeda K, Amano F, Kato R, Ijiri Y, Tanaka K. 2007. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells. Biol Pharm Bull. 30(10):1982–1986.
   PubMed Web of Science ®Google Scholar
• Yamasaki Y, Ieiri I, Kusuhara H, Sasaki T, Kimura M, Tabuchi H, Ando Y, Irie S, Ware J, Nakai Y, et al. 2008. Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans. Clin Pharmacol Ther. 84(1):95–103.
   PubMed Web of Science ®Google Scholar
• Yco LP, Geerts D, Mocz G, Koster J, Bachmann AS. 2015. Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target. Bmc Cancer. 15:477.
   PubMed Web of Science ®Google Scholar
• Zhai XJ, Chen JG, Liu JM, Shi F, Lu YN. 2013. Food–drug interactions: effect of capsaicin on the pharmacokinetics of simvastatin and its active metabolite in rats. Food Chem Toxicol. 53:168–173.
   PubMed Web of Science ®Google Scholar
• Zhang LL, Yan Liu D, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ, et al. 2007. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res. 100(7):1063–1070.
   PubMed Web of Science ®Google Scholar